Cocrystal Pharma (COCP) vs Quantum Biopharma (QNTM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cocrystal Pharma (COCP) has outperformed Quantum Biopharma (QNTM) over the past year, losing 14.4% versus a loss of 80.3%. Over five years, COCP leads with a -90.5% price change compared with -96.7% for QNTM. Cocrystal Pharma is the larger company by market cap ($20.6 million vs $20.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COCP | QNTM |
|---|---|---|
| Share price | $1.07 | $3.11 |
| Market cap | $20.61M | $20.00M |
| 1-day change | 0.00% | -1.11% |
| YTD return | +9.18% | -57.40% |
| 1-year return | -14.40% | -80.28% |
| 5-year return | -90.51% | -96.65% |
| EPS (TTM) | $-0.76 | $-4.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.03 | $16.36 |
| 52-week low | $0.76 | $2.07 |
| Distance from 52-week high | -47.29% | -80.99% |
| Analyst consensus | none | none |
| Avg. price target upside | +741.12% | +294.53% |
| Average volume | 56.00K | 205.30K |
| Shares outstanding | 19.26M | 6.43M |
| Employees | 10 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- COCP has outperformed QNTM by 65.9 percentage points over the past year.
About Cocrystal Pharma
COCP stock →Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
About Quantum Biopharma
QNTM stock →Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Health Care · Biotechnology: Pharmaceutical Preparations
COCP vs QNTM FAQ
Which is bigger, Cocrystal Pharma or Quantum Biopharma?
Cocrystal Pharma (COCP) is larger, with a market capitalization of $20.61M compared with $20.00M for Quantum Biopharma (QNTM).
Which stock has performed better over the past year, COCP or QNTM?
COCP returned -14.40% over the past 12 months, compared with -80.28% for QNTM (price return, excluding dividends). Past performance does not predict future results.
Are Cocrystal Pharma and Quantum Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.